A team at Kagawa University has been collaborating for more than 20 years with researchers at manufacturer Matsutani Chemical Industry Co., Ltd, which produces and sells D-allulose
The biggest concern we have from a medical standpoint is that patients who lose weight quickly and without significantly changing their lifestyle are prone to gaining more weight once they stop the drug
That means we have limited data on how these drugs work in the real world for diverse patients, and we risk reinforcing disparities if access remains limited
"Over the past two decades, the prevalence of type 2 diabetes among children and adolescents has increased substantially, yet treatment options for this population remain limited, underscoring a significant unmet need
Are you considering purchasing Tirzepatide online for weight loss or diabetes management
One more thing: For now, there are no generic versions of GLP-1s like Ozempic and Wegovy